z-logo
open-access-imgOpen Access
Analysis of compensation policies for executives and directors of bio-pharmaceutical companies in the context of the global spread of COVID-19
Author(s) -
Linzhuo Lyu
Publication year - 2022
Publication title -
bcp business and management
Language(s) - English
Resource type - Journals
ISSN - 2692-6156
DOI - 10.54691/bcpbm.v28i.2224
Subject(s) - incentive , business , compensation (psychology) , context (archaeology) , cash , order (exchange) , accounting , covid-19 , executive compensation , marketing , corporate governance , economics , finance , infectious disease (medical specialty) , psychology , medicine , paleontology , disease , pathology , psychoanalysis , biology , microeconomics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom